As proliferation rate is an important factor determining the tumour aggressiveness, the evaluation of PCNA index (the percentage of PCNA- immunopositive nuclei in the investigated tissue sample) is suggested as useful in evaluating the malignancy of breast cancer. This evidence concerns the gene PCNA and breast cancer.